Regulation of Eukaryotic Initiation Factor 4E (eIF4E) Phosphorylation by Mitogen-Activated Protein Kinase Occurs through Modulation of Mnk1-eIF4G Interaction

被引:109
作者
Shveygert, Mayya [1 ]
Kaiser, Constanze [1 ]
Bradrick, Shelton S. [2 ]
Gromeier, Matthias [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
关键词
D O I
10.1128/MCB.00448-10
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The m(7)G cap binding protein eukaryotic initiation factor 4E (eIF4E) is a rate-limiting determinant of protein synthesis. Elevated eIF4E levels, commonly associated with neoplasia, promote oncogenesis, and phosphorylation of eIF4E at Ser209 is critical for its tumorigenic potential. eIF4E phosphorylation is catalyzed by mitogen-activated protein kinase (MAPK)-interacting serine/threonine kinase (Mnk), a substrate of Erk1/2 and p38 MAPKs. Interaction with the scaffolding protein eIF4G, which also binds eIF4E, brings Mnk and its substrate into physical proximity. Thus, Mnk-eIF4G interaction is important for eIF4E phosphorylation. Through coimmunoprecipitation assays, we showed that MAPK-mediated phosphorylation of the Mnk1 active site controls eIF4G binding. Utilizing a naturally occurring splice variant, we demonstrated that the C-terminal domain of Mnk1 restricts its interaction with eIF4G, preventing eIF4E phosphorylation in the absence of MAPK signaling. Furthermore, using a small-molecule Mnk1 inhibitor and kinase-dead mutant, we established that Mnk1 autoregulates its interaction with eIF4G, releasing itself from the scaffold after phosphorylation of its substrate. Our findings indicate tight control of eIF4E phosphorylation through modulation of Mnk1-eIF4G interaction.
引用
收藏
页码:5160 / 5167
页数:8
相关论文
共 23 条
[1]   Identification of Gemin5 as a Novel 7-Methylguanosine Cap-Binding Protein [J].
Bradrick, Shelton S. ;
Gromeier, Matthias .
PLOS ONE, 2009, 4 (09)
[2]   MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates [J].
Fukunaga, R ;
Hunter, T .
EMBO JOURNAL, 1997, 16 (08) :1921-1933
[3]   eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression [J].
Furic, Luc ;
Rong, Liwei ;
Larsson, Ola ;
Koumakpayi, Ismael Herve ;
Yoshida, Kaori ;
Brueschke, Andrea ;
Petroulakis, Emmanuel ;
Robichaud, Nathaniel ;
Pollak, Michael ;
Gaboury, Louis A. ;
Pandolfi, Pier Paolo ;
Saad, Fred ;
Sonenberg, Nahum .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (32) :14134-14139
[4]   eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation [J].
Gingras, AC ;
Raught, B ;
Sonenberg, N .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :913-963
[5]   The C-terminal domain of Mnk1a plays a dual role in tightly regulating its activity [J].
Goto, Susan ;
Yao, Zhong ;
Proud, Christopher G. .
BIOCHEMICAL JOURNAL, 2009, 423 :279-290
[6]   Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment [J].
Ralf Jauch ;
Min‐Kyu Cho ;
Stefan Jäkel ;
Catharina Netter ;
Kay Schreiter ;
Babette Aicher ;
Markus Zweckstetter ;
Herbert Jäckle ;
Markus C Wahl .
The EMBO Journal, 2006, 25 (17) :4020-4032
[7]   Activation of cap-independent translation by variant eukaryotic initiation factor 4G in vivo [J].
Kaiser, Constanze ;
Dobrikova, Elena Y. ;
Bradrick, Shelton S. ;
Shveygert, Mayya ;
Herbert, James T. ;
Gromeier, Matthias .
RNA, 2008, 14 (10) :2170-2182
[8]   Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2 [J].
Knauf, U ;
Tschopp, C ;
Gram, H .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) :5500-5511
[9]   MALIGNANT TRANSFORMATION BY A EUKARYOTIC INITIATION-FACTOR SUBUNIT THAT BINDS TO MESSENGER-RNA 5' CAP [J].
LAZARISKARATZAS, A ;
MONTINE, KS ;
SONENBERG, N .
NATURE, 1990, 345 (6275) :544-547
[10]   eIF4E - from translation to transformation [J].
Mamane, Y ;
Petroulakis, E ;
Rong, LW ;
Yoshida, K ;
Ler, LW ;
Sonenberg, N .
ONCOGENE, 2004, 23 (18) :3172-3179